Online citations, reference lists, and bibliographies.

Riluzole-loaded Nanoparticles To Alleviate The Symptoms Of Neurological Disorders By Attenuating Oxidative Stress

Bushra Nabi, Saleha Rehman, M. Fazil, S. Khan, S. Baboota, J. Ali
Published 2020 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Purpose: The objective of the research undertaken was to develop the Riluzole (RIZ) nanoparticles drug delivery system using Transferrin (Tf) as a ligand in the brain. Method: RIZ-loaded chitosan nanoparticles and RIZ-Tf chitosan (CS) nanoparticles (RIZ CSNPs and RIZ-Tf CSNPs) were formulated and compared for particles size, size distribution, encapsulation efficiency, and surface morphology, respectively. The in vitro drug release, permeation, pharmacokinetic, biochemical, and pharmacodynamic experiments were done to assess the improvement in in vivo fate and efficacy of RIZ. Results: The size of optimized RIZ CSNPs was found to be 173.6 ± 2.23 nm and polydispersity index (PDI) of 0.264 ± 0.002 while that of RIZ-Tf CSNPs was 207 ± 2.49 nm and 0.406 ± 0.002. In vitro release was found to be 86.15 ± 7.316% and 91.1 ± 5.836%, respectively, while permeability coefficient was found to be 4 × 10−2 and 4.2 × 10−2 cm/s for RIZ CSNPs and RIZ-Tf CSNPs. The biochemical analysis studies revealed that oxidative stress was significantly decreased in case of RIZ CSNPs and RIZ-Tf CSNPs (p < 0.01) treated groups. The antianxiety effect and the memory restoration were evident in pharmacodynamic studies (p < 0.05) of the prepared formulations. Conclusion: The results of pharmacokinetic studies demonstrated the remarkable brain delivery of RIZ-Tf CSNPs through intranasal route as compared to the RIZ solution.
This paper references
10.7243/2052-6946-1-3
Central nervous system diseases and the role of the blood-brain barrier in their treatment
A. Domínguez (2013)
Kinetic modeling on drug release from controlled drug delivery systems.
Suvakanta Dash (2010)
10.1073/pnas.1307152110
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
Devin T. Wiley (2013)
10.2174/138161210791164108
Potential of nanoparticulate drug delivery systems by intranasal administration.
J. Ali (2010)
Development and characterization of atorvastatin calcium loaded chitosan nanoparticles for sustain drug
A Bathool (2012)
10.1080/03639045.2016.1236811
Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection
Julien Maincent (2017)
10.1080/03639045.2018.1518455
Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil
M. Mohammed (2019)
10.3109/1061186X.2011.611518
Recent advances in ligand targeted therapy
G. Trapani (2012)
10.1155/2017/8274927
Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir
Saleha Rehman (2017)
10.1016/J.JCHROMB.2004.11.053
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection.
A. Maltese (2005)
The intranasal gels of Box-Behnken experimental design for preparation and optimization of selegiline hydrochloride
S Salatin (2018)
10.3109/10717544.2014.910566
Preparation of surface multiple-coated polylactide acid drug-loaded nanoparticles for intranasal delivery and evaluation on its brain-targeting efficiency
Junjie Bian (2016)
10.2147/IJN.S151474
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
Qingqing Meng (2018)
10.1111/j.1460-9568.2010.07579.x
Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block
Alessandra Cifra (2011)
10.1016/J.JDDST.2019.06.014
Intranasal dolutegravir sodium loaded nanoparticles of hydroxypropyl-beta-cyclodextrin for brain delivery in Neuro-AIDS
A. Belgamwar (2019)
10.5185/AMLETT.2013.ICNANO.108
Synthesis and characterization of silver nanoparticles embedded in polyaniline nanocomposite
Y. Wankhede (2013)
10.1016/j.carbpol.2012.02.051
Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
S. Haque (2012)
10.1080/03639045.2017.1402918
Development of zolmitriptan transfersomes by Box–Behnken design for nasal delivery: in vitro and in vivo evaluation
Shravan Kumar Pitta (2018)
COMPARATIVE ANXIOLYTIC ACTIVITY OF VARIOUS DRUGS IN EXPERIMENTAL MODELS OF RATS
Kedare Rahul Vitthal (2012)
10.1016/j.ijpharm.2008.03.029
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
M. Kumar (2008)
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
10.1136/bmj.e7500
Generalized anxiety disorder: diagnosis and treatment
E. Hoge (2012)
10.1016/0003-2697(79)90738-3
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.
H. Ohkawa (1979)
10.5185/AMLETT.2012.ICNANO.153
Development and characterization of atorvastatin calcium loaded chitosan nanoparticles for sustain drug delivery
Afifa Bathool (2012)
10.1080/03639045.2019.1619759
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery
Rajalakshmi Rukmangathen (2019)
10.1016/j.ejps.2012.04.013
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
M. Fazil (2012)
Depressive Disorders in Indian Context : A Review and Clinical Update for Physicians.
R. D. Pattanayak (2014)
10.1016/j.colsurfb.2011.09.042
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
W. Fan (2012)
Nanoparticles: An Advance Technique for Drug Delivery
Kuldeep Malodia (2012)
10.1089/neu.1996.13.767
Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
T. Mcintosh (1996)
10.1016/S1474-4422(13)70036-X
Controversies and priorities in amyotrophic lateral sclerosis
M. Turner (2013)
10.1016/j.ejps.2012.12.007
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
10.3109/10717544.2014.907372
Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route
Deepti Mittal (2016)
Chitosan and chitosan: ethylene oxide-propylene oxide block copolymer 482 B. NABI ET AL. NPs as novel carriers for proteins and vaccines
P Calvo (1997)
Novel instantlydispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies and in-vivo evaluation
SA Fouad (2018)
10.3109/03639045.2015.1062897
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain
A. Hanafy (2015)
10.1016/j.ejpb.2010.07.007
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Shrinidh A Joshi (2010)
Nanoparticle: An overview of preparation and characterization
S. Pal (2011)
10.1016/j.neuint.2011.10.017
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
M. Carbone (2012)
Venlafaxine loaded chitosan nanoparticles for brain targeting: pharmacokinetic and pharmacodynamic evaluation
S Haque (2012)
10.3109/10717544.2013.838014
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
H. Mahajan (2014)
10.3390/nano8110920
Synthesis and Optimization of Chitosan Nanoparticles Loaded with l-Ascorbic Acid and Thymoquinone
N. Othman (2018)
10.1016/S0142-9612(00)00421-X
Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates.
C. Kast (2001)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1080/03639045.2017.1411941
Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 23 full-factorial design and in vivo determination of GABA neurotransmitter
E. Abd-Elrasheed (2018)
10.1080/03639045.2017.1338721
In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting
Mayuri Ahirrao (2017)
10.3109/03639045.2014.991400
Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting
Omidreza Jafarieh (2015)
10.2147/IJN.S39685
Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
L. Zhang (2013)
10.1016/j.apsb.2014.10.005
Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation
Mohd Yasir (2014)
10.1080/03639045.2018.1459675
Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation
Shahinaze A Fouad (2018)
10.1016/0003-2697(68)90092-4
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.
J. Sedlak (1968)
10.1016/J.CARBPOL.2007.11.007
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Sofia A. Papadimitriou (2008)
10.1016/j.ejpb.2015.06.002
Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin.
J. Li (2015)
10.3390/pharmaceutics11010026
Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
A. S. Tzeyung (2019)
10.1080/03639045.2016.1236808
Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability
J. A. Kulkarni (2017)
10.1016/J.BIOMATERIALS.2004.03.011
Synthesis and in vitro evaluation of a novel thiolated chitosan.
K. Kafedjiiski (2005)
10.1080/03639045.2018.1483387
Box–Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride
S. Salatin (2018)
10.1016/j.actbio.2011.07.025
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.
U. Seju (2011)
10.3109/10611860903386938
Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats
S. Khan (2010)
10.4103/0253-7613.96337
Pharmacological investigation of memory restorative effect of riluzole in mice
P. Rinwa (2012)
10.1096/fj.09-129825
Surface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sneha Sundaram (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar